An advanced gastrointestinal endoscopist by training, Dr. Anandasabapathy’s research focus involves the development and validation of novel technologies for the diagnosis of early gastrointestinal cancer. She is currently the principal investigator on three grants funded by the National Institutes of Health and National Cancer Institute and on eight clinical trials focused on the development of low-cost, battery-operated, portable technologies for the endoscopic diagnosis of esophageal, gastric and colon cancers. These trials are currently being conducted in the United States, Africa, China, Mexico and Honduras.

Dr. Anandasabapathy and her group also are involved in several projects that seek to develop innovative technological approaches to addressing cancer and other chronic diseases in low-resource areas, such as West Africa (The Gambia), India, China and Central America. These involve the development of tablet-based reporting and documentation platforms, sedation/anesthesia and procedure-based training modules, and environmentally appropriate innovations (battery-operated technologies, etc.). These partnerships involve active, extensive collaborations with other academic centers (Icahn School of Medicine at Mount Sinai, Rice University, Harvard University), non-governmental organizations and foundations.

In addition to her primary appointment at Baylor, Dr. Anandasabapathy holds an adjunct appointment in bioengineering at Rice University in Houston, Texas. She holds a B.A. in English literature from Yale University and an M.D. from the Albert Einstein College of Medicine. She completed her internal medicine training at the New York Hospital-Cornell Medical Center and Memorial Sloan Kettering Cancer Center and her gastroenterology fellowship at The Mount Sinai Medical Center, New York.